LINC01337: A Long Intergenic Non-Protein Coding RNA (G103689917)

Target Name: LINC01337

NCBI ID: G103689917

LINC01337

Other Name(s): long intergenic non-protein coding RNA 1337 | Long intergenic non-protein coding RNA 1337 | TCONS_00009713

LINC01337: A Long Intergenic Non-Protein Coding RNA

Non-Protein-Coding RNAs (NP-C RNAs) have emerged as a promising candidate for drug targeting and disease diagnosis. These RNAs are generated from genomic regions that are not known to code for protein sequences, but can be expressed and translated into functional proteins or RNA molecules. One of the most well-studied NP-C RNAs is LINC01337, which has been shown to play a role in various biological processes and is considered a potential drug target or biomarker.

LINC01337 is a long intergenic non-protein-coding RNA (lncRNA) that was identified using RNA sequencing (RNA-seq) data. It has a length of approximately 2,421 nucleotides and is located between the intron-exon boundaries of exons 12 and 13 of the HASN gene on chromosome 16. LINC01337 is 100% conserved in mouse, human, and human HASN gene.

LINC01337 is expressed in various tissues and cells

LINC01337 is highly expressed in the brain, heart, liver, and muscle tissues of mouse, human, and human. It is also expressed in various cell types, such as blood cells, immune cells, and cancer cells. LINC01337 is highly expressed in the testes of mice and has been shown to play a role in germ cell development and meiosis.

LINC01337 is involved in various biological processes

LINC01337 is involved in various biological processes, including cell growth, cell cycle, DNA replication, and apoptosis. It is a positive regulator of the cell cycle and is required for the G1/S transition. LINC01337 is also involved in DNA replication and has been shown to be involved in the regulation of DNA replication in various cell types. LINC01337 is a negative regulator of apoptosis and has been shown to play a role in the regulation of apoptosis in various cell types (9 ).

LINC01337 is a potential drug target

LINC01337 is a potential drug target due to its involvement in various biological processes and its expression in various tissues and cell types. Its expression in the brain, heart, and liver tissues makes it a potential target for neurodegenerative diseases. LINC01337 is also involved in the regulation of cell cycle and DNA replication, which makes it a potential target for cancer therapies. Additionally, its role in apoptosis makes it a potential target for anti-apoptotic drugs.

In conclusion, LINC01337 is a long intergenic non-protein-coding RNA that is involved in various biological processes and is expressed in various tissues and cell types. Its potential as a drug target or biomarker makes it an attractive target for future research. Further studies are needed to determine the role of LINC01337 in various biological processes and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 1337

The "LINC01337 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01337 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets